Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
about
Targeting the latent reservoir to achieve functional HIV cureEditing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and PlasticityAchieving HIV-1 Control through RNA-Directed Gene RegulationAntiretroviral therapy: Shifting sandsReactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.Gene Editing for Treatment of Neurological Infections.The variances of Sp1 and NF-κB elements correlate with the greater capacity of Chinese HIV-1 B'-LTR for driving gene expression.Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.CRISPR-Cas9 technology and its application in haematological disorders.Stem cell-based therapies for HIV/AIDS.A CRISPR Approach for Reactivating Latent HIV-1.CRISPR/Cas9: a double-edged sword when used to combat HIV infection.Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants.Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era.Cell and Gene Therapy for HIV Cure.Genome editing technologies to fight infectious diseases.CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy.Ultrasound-targeted microbubble destruction-mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function.Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy.Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.Stable Transcriptional Repression and Parasitism of HIV-1.Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling
P2860
Q26745923-F1EC0CCF-57D5-4D6C-938D-86C2672DDB86Q28075883-BEC06593-5073-4C50-B8BE-563B52CCD91EQ28080090-CDF5B933-0759-4D6C-91B4-42334EA96849Q30384683-9A5037FE-F319-4AC4-ACA7-D8C1EBA8EEA4Q35942658-995FDE1B-1363-43E9-859D-6E891B0D93A6Q36060923-44F8D3A4-0237-489B-9F70-E8DD7E639FB0Q36216276-159B4303-3EAB-430E-9E90-A26593DADAD0Q36675349-2B9CD0C1-A357-4C09-9CAF-566FDCFE883CQ36730743-30963A32-F6C5-4E69-83B8-DF625630089BQ37136471-DFACADA0-77A4-4C66-BC12-ECF714348D10Q37307353-013E12D4-F6DB-444E-A267-B0AFC4A73DEFQ38687781-82E4A129-3F96-4CA0-A03B-91F3F4A24D19Q38822073-B5EBA15D-8388-4F61-9D0C-F82F4FB6E327Q38827119-26A587C3-4271-4948-8BCB-A68F2F950BA4Q38919964-4CAB1511-4845-4CE2-ABEF-B27DB28F8936Q40657354-A946B9A4-A253-4DB3-B26E-2526E704A532Q43212335-96F08C3D-0186-430E-85C4-8A1CA50D85A3Q45875539-F7C06DDD-8C8C-405F-A71A-BCEDE29424F6Q47236016-049188BE-CF27-40AF-8B0E-DBEE89ECE8FDQ47392998-328E842D-1909-4455-A477-86FE5C928F07Q47553089-5ACAE506-82E0-4BAC-9A4D-2BA68703F8C1Q49462231-F4CBF99C-C88C-4B93-8C15-C8CF230B9E4AQ49882362-75D6A38F-F0CE-4EA2-8519-7BDD60308204Q50111348-3306052B-92C1-4011-BCB9-CEE49F4E5E4BQ52431127-D9C8E5B6-E57B-4BF4-9AF5-278CC3305780Q55399452-87C57918-85A4-4A6F-8036-A3CCB75C7C7FQ58755636-3AB08718-307E-452D-BE0F-EFFE8CB48198
P2860
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
@en
type
label
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
@en
prefLabel
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
@en
P2093
P2860
P50
P356
P1433
P1476
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
@en
P2093
Daniel C Lazar
Marc S Weinberg
Mayumi Takahashi
Sheena M Saayman
Tristan A Scott
Vicente Planelles
P2860
P304
P356
10.1038/MT.2015.202
P577
2015-11-19T00:00:00Z